Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and without on-site revascularization facilities in Canada

被引:39
作者
Alter, DA
Tu, JV
Austin, PC
Naylor, CD
机构
[1] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada
[2] Sunnybrook & Womens Coll Hlth Sci Ctr, Schulich Heart Ctr, Div Cardiol, Toronto, ON, Canada
[3] Univ Toronto, Fac Med, Toronto, ON, Canada
[4] Univ Toronto Clin Epidemiol, Toronto, ON, Canada
[5] Hlth Care Res Program, Toronto, ON, Canada
[6] Sunnybrook & Womens Coll Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON, Canada
[7] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada
[8] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada
关键词
D O I
10.1016/S0735-1097(03)00640-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study was designed to determine whether admission to a Canadian hospital with on-site revascularization (invasive hospital) affected revascularization choice, timing, and outcome compared with community (non-invasive) hospitals. BACKGROUND Health care systems in Canada are characterized by relative restraint in diffusion of tertiary cardiovascular services, with capacity for revascularization procedures concentrated in large regional referral centers. METHODS We used linked administrative data and a clinical registry to follow-up 15,166 Ontario patients who underwent revascularization within the year after their index acute myocardial infarction (MI). Outcomes included recurrent urgent cardiac hospitalization, hospital bed-days, and death within the same year after the index admission. We adjusted for age, gender, socioeconomic status, illness severity, attending physician specialty, and academic hospital affiliation. RESULTS After adjusting for baseline factors, patients admitted to invasive hospitals were more likely to receive angioplasty than bypass surgery (adjusted odds ratio: 1.85; 95% confidence interval: 1.68 to 2.04, p < 0.001). The converse pattern was seen for patients admitted to community hospitals. Median revascularization waiting times were significantly shorter at invasive hospitals (12 vs. 48 days, p < 0.001). Patients admitted to invasive hospitals had fewer cardiac re-admissions (41.5 vs. 68.9 events per 100 patients, p < 0.001) before their first revascularization and consumed fewer hospital bed-days (379 vs. 517 per 100 patients, p < 0.001). There were no differences in outcomes beyond revascularization. CONCLUSIONS Outcome advantages associated with timely post-MI revascularization highlight the importance of organizing revascularization referral networks and facilitating access to revascularization for patients with acute coronary syndromes admitted to community hospitals in Canada. (C) 2003 by the American College of Cardiology Foundation.
引用
收藏
页码:410 / 419
页数:10
相关论文
共 26 条
[1]  
Alderman EL, 1996, NEW ENGL J MED, V335, P217
[2]   Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction [J].
Alter, DA ;
Naylor, CD ;
Austin, P ;
Tu, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (18) :1359-1367
[3]   Long term MI outcomes at hospitals with or without on-site revascularization [J].
Alter, DA ;
Naylor, CD ;
Austin, PC ;
Tu, JV .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (16) :2101-2108
[4]  
[Anonymous], CARDIOVASCULAR HLTH
[5]   A comparison of US and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: Efficiency, yield and long-term implications [J].
Batchelor, WB ;
Peterson, ED ;
Mark, DB ;
Knight, JD ;
Granger, CB ;
Armstrong, PW ;
Califf, RM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (01) :12-19
[6]   HIGH-TECHNOLOGY CARDIAC PROCEDURES - THE IMPACT OF SERVICE AVAILABILITY ON SERVICE USE IN NEW-YORK-STATE [J].
BLUSTEIN, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (03) :344-349
[7]   Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. [J].
Cannon, CP ;
Weintraub, WS ;
Demopoulos, LA ;
Vicari, R ;
Frey, MJ ;
Lakkis, N ;
Neumann, FJ ;
Robertson, DH ;
DeLucca, PT ;
DiBattiste, PM ;
Gibson, CM ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1879-1887
[8]  
*CARD CAR NETW ONT, 2000, TARG SETT WORK GROUP
[9]   INTERNATIONAL COMPARISON OF WAITING-TIMES FOR SELECTED CARDIOVASCULAR PROCEDURES [J].
CARROLL, RJ ;
HORN, SD ;
SODERFELDT, B ;
JAMES, BC ;
MALMBERG, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (03) :557-563
[10]  
Chapple A, 1998, J Health Serv Res Policy, V3, P153